The weekly litigation news digest is live. Subscribe now

IP Verse

Pyridone Compound As C-Met Inhibitor - EP3533787

The patent EP3533787 was granted to Fujian Cosunter Pharmaceutical on Sep 30, 2020. The application was filed on Oct 27, 2017 under application number EP17864813A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP3533787

FUJIAN COSUNTER PHARMACEUTICAL
Application Number
EP17864813A
Filing Date
Oct 27, 2017
Status
Opposition Rejected
May 9, 2025
Publication Date
Sep 30, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MERCK PATENTJun 30, 2021MEWBURN ELLISADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
OPPOSITIONWO2008103277
OPPOSITIONWO2009006959
SEARCHWO2010072296

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents